Article Versions Notes

Rahimi S, van Leeuwen D, Roshanzamir F, Pandit S, Shi L, Sasanian N, Nielsen J, Esbjörner EK, Mijakovic I. Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells. Pharmaceutics. 2023; 15(2):391. https://doi.org/10.3390/pharmaceutics15020391

Rahimi, Shadi, Daniel van Leeuwen, Fariba Roshanzamir, Santosh Pandit, Lei Shi, Nima Sasanian, Jens Nielsen, Elin K. Esbjörner, and Ivan Mijakovic. 2023. "Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells" Pharmaceutics 15, no. 2: 391. https://doi.org/10.3390/pharmaceutics15020391

Rahimi, S., van Leeuwen, D., Roshanzamir, F., Pandit, S., Shi, L., Sasanian, N., Nielsen, J., Esbjörner, E. K., & Mijakovic, I. (2023). Ginsenoside Rg3 Reduces the Toxicity of Graphene Oxide Used for pH-Responsive Delivery of Doxorubicin to Liver and Breast Cancer Cells. Pharmaceutics, 15(2), 391. https://doi.org/10.3390/pharmaceutics15020391